Related Experiment Video
Updated: Feb 8, 2026

DNA Vector-based RNA Interference to Study Gene Function in Cancer
Published on: June 4, 2012
Inducible Caspase9-mediated suicide gene for MSC-based cancer gene therapy
Filippo Rossignoli1, Giulia Grisendi2,3, Carlotta Spano2,3
1Division of Oncology, Department of Medical and Surgical Sciences for Children & Adults, University-Hospital of Modena and Reggio Emilia, Modena, Italy. filippo.rossignoli@unimore.it.
Abstract:
Cellular therapies based on mesenchymal stromal/stem cells (MSC) are promising strategies in regenerative medicine and oncology. Despite encouraging results, there is still some level of concerns on inoculating MSC in cancer patients. To face this issue, one possibility resides in engineering MSC by incorporating a suicide gene in order to control their fate once infused. Strategies based on Herpes Simplex Virus Thymidine Kinase (HSV-TK) and the Cytosine Deaminase genes have been developed and more recently a novel suicide gene, namely, iCasp9, has been proposed. This approach is based on a variant of human Caspase9 that binds with high affinity to a synthetic, bioinert small molecule (AP20187) leading to cell death. Based on this technology so far marginally applied to MSC, we tested the suitability of iCasp9 suicide strategy in MSC to further increase their safety. MSC have been transfected by a lentiviral vector carrying iCasp9 gene and then tested for viability after AP20187 treatment in comparison with mock-transfected cells. Moreover, accounting our anti-tumor approaches based on MSC expressing potent anti-cancer ligand TNF-Related Apoptosis-Inducing Ligand (TRAIL), we generated adipose MSC co-expressing iCasp9 and TRAIL successfully targeting an aggressive sarcoma type. These data show that anti-cancer and suicide mechanisms can coexist without affecting cells performance and hampering the tumoricidal activity mediated by TRAIL. In conclusion, this study originally indicates the suitability of combining a MSC-based anti-cancer gene approach with iCasp9 demonstrating efficiency and specificity.
Insights
Engineered mesenchymal stromal/stem cells (MSC) with a novel suicide gene (iCasp9) offer enhanced safety for cancer therapy. These modified MSCs, co-expressing anti-cancer TRAIL, effectively target tumors without compromising efficacy.
Area of Science:
- Cellular and Molecular Oncology
- Regenerative Medicine
- Gene Therapy
Background:
- Mesenchymal stromal/stem cells (MSC) show therapeutic promise in regenerative medicine and oncology.
- Concerns exist regarding MSC safety in cancer patients, necessitating methods to control infused cell fate.
- Existing suicide gene strategies (HSV-TK, Cytosine Deaminase) have limitations.
Purpose of the Study:
- To evaluate the suitability of the inducible Caspase 9 (iCasp9) suicide gene system for enhancing MSC safety.
- To develop and test adipose-derived MSCs engineered to co-express iCasp9 and TNF-Related Apoptosis-Inducing Ligand (TRAIL) for combined anti-cancer therapy.
Main Methods:
- MSC transfection using a lentiviral vector encoding the iCasp9 suicide gene.
- Assessment of iCasp9-expressing MSC viability upon treatment with the small molecule inducer AP20187.
- Generation of adipose MSCs co-expressing iCasp9 and TRAIL for targeting aggressive sarcoma models.
Main Results:
- iCasp9 effectively induced cell death in transfected MSCs upon AP20187 administration, confirming its function as a suicide gene.
- Co-expression of iCasp9 and TRAIL in MSCs did not impair their anti-cancer activity against sarcoma.
- The combined approach demonstrated that safety mechanisms (iCasp9) and therapeutic functions (TRAIL) can coexist in engineered MSCs.
Conclusions:
- The iCasp9 suicide gene system is a suitable and effective strategy for enhancing the safety of MSC-based cancer therapies.
- Combining iCasp9 with MSC-mediated anti-cancer gene delivery, such as TRAIL, offers a potent and controllable therapeutic approach.
- This study validates the dual functionality of engineered MSCs for both safety and targeted tumoricidal activity.
Related Concept Videos
Gene Therapy
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Gene Flow
Gene Families
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...
Gene Conversion
What is Gene Expression?
Gene expression is the process in which DNA directs the synthesis of functional products, that is, proteins. Cells can regulate gene expression at various stages. It allows organisms to generate different cell types and enables cells to adapt to internal and external factors.
Genetic Information Flows from DNA to RNA to Protein
A gene is a stretch of DNA that serves as the blueprint for functional RNAs and proteins. Since DNA is made up of nucleotides and proteins consist of amino...

